Shanghai, China – Lubrizol, a global leader in specialty chemicals, and SIRIO, a well-established global nutrition product solution provider, announced the signing of a Strategic Cooperation Memorandum of Understanding (MOU) to jointly advance the innovation and commercialization of microencapsulated nutritional ingredients. The collaboration brings together Lubrizol's and SIRIO’s expertise to accelerate the development of next-generation nutritional health products for consumers.

Under the MOU, Lubrizol will provide technical support across ingredient selection, fundamental research, process development, customized specification development, pilot-scale studies, scientific publications, clinical research and post-commercialization services for microencapsulated nutritional ingredients. SIRIO will contribute its expertise in formulation development, dosage-form innovation, manufacturing, market promotion, and consumer education to support faster product development and commercialization.

As a leading technology and ingredient supplier to the nutrition and pharmaceutical industries, Lubrizol’s portfolio of branded microencapsulated ingredients—including LIPOFER™ microencapsulated iron, MAGSHAPE™ microencapsulated magnesium, CURCUSHINE™ microencapsulated curcumin, ZINCNOVA™ microencapsulated zinc and LIPOCAL™ microencapsulated calcium—helps improve the bioavailability, stability and sensory experience of minerals and other active ingredients. These technologies are designed to improve nutrient delivery, product stability and sensory experience, enabling brands to create differentiated nutritional products that better meet consumer expectations.

"Lubrizol has deep expertise in microencapsulation technology." said Kevin Song, Senior Global Business Director, Lubrizol. "Our goal is to help customers differentiate their products through science-backed branded ingredients that deliver meaningful consumer benefits. By combining our ingredient innovation with SIRIO's world-class formulation expertise and global manufacturing capabilities, we can accelerate the development of innovative nutritional solutions that raise industry standards and ultimately improve human health and well-being."

As a leading global nutrition product solution provider, SIRIO operates seven automated manufacturing facilities and five R&D centers worldwide, supported by its proprietary E³ Biomimetic Enhancement Technology Platform. By integrating Lubrizol's advanced microencapsulated ingredients with its formulation expertise and comprehensive dosage-form capabilities, SIRIO provides brand owners with end-to-end solutions spanning market insights, product development and commercial production.

"Consumers are looking for nutritional products that are more effective, convenient and enjoyable to use," said Mr. Zhou Qinggao, Head of Strategic Procurement, SIRIO. "This partnership enables us to help brands develop differentiated products with stronger performance and consumer appeal. We look forward to working closely with Lubrizol to bring more innovative, science-based nutritional solutions to the market."

Lubrizol and SIRIO Sign Memorandum of Understanding to Advance Innovation and Commercialization of Microencapsulated Nutritional Solutions